Fresenius Medical Care AG (FMS)

NYSE: FMS · Real-Time Price · USD

25.66

-0.04 (-0.16%)

At close: Jul 31, 2026, 4:00 PM EDT

25.67

+0.01 (0.04%)

After-hours: Jul 31, 2026, 7:34 PM EDT

Fresenius Medical Care AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,239	1,599	1,180	1,403	1,274	1,482
Cash & Short-Term Investments	1,239	1,599	1,180	1,403	1,274	1,482
Cash Growth	15.67%	35.50%	-15.91%	10.18%	-14.03%	36.99%
Accounts Receivable	3,582	3,142	3,367	3,471	3,574	3,409
Other Receivables	133.39	158.88	40.94	165.3	140.07	162.36
Total Trade Receivables	3,715	3,301	3,408	3,637	3,714	3,571
Inventory	2,303	2,141	2,068	2,179	2,296	2,038
Other Current Assets	850.37	857.34	1,267	1,482	919.11	876.15
Total Current Assets	8,108	7,898	7,923	8,701	8,203	7,967
Net Property, Plant & Equipment	6,443	6,500	7,259	7,454	8,340	8,551
Other Intangible Assets	1,257	1,254	1,370	1,362	1,519	1,459
Goodwill	13,846	13,571	15,171	14,650	15,791	14,362
Long-Term Investments	1,330	1,323	1,417	1,255	1,390	786.91
Other Long-Term Assets	482.88	454.77	427.83	507.53	511.47	1,240
Total Assets	31,468	31,002	33,567	33,930	35,754	34,367

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	890.43	835.55	984.32	885.15	951.58	857.53
Accrued Expenses	-	-	1,500	1,617	1,568	3,677
Short-Term Debt	120.97	17.02	2.1	456.9	648.77	1,256
Current Portion of Long-Term Debt	1,675	1,596	575.28	487.7	694.06	667.97
Current Portion of Leases	593.28	584.29	640.88	616.96	673.83	661.58
Other Current Liabilities	3,298	3,073	1,958	2,047	1,931	137.84
Total Current Liabilities	6,730	6,245	5,660	6,112	6,467	7,258
Long-Term Debt	5,741	5,692	6,261	6,960	7,171	6,647
Long-Term Leases	2,899	2,906	3,500	3,529	4,005	4,088
Other Long-Term Liabilities	2,045	2,016	2,377	2,503	2,662	2,395
Total Long-Term Liabilities	10,533	10,474	12,138	12,992	13,838	13,130
Total Liabilities	17,263	16,720	17,798	19,103	20,305	20,388

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	293.41	293.41	293.41	293.41	293.41	293
Treasury Stock	-940.59	-586.09	-	-	-	-
Additional Paid-in Capital	3,026	3,079	3,345	3,380	3,373	2,891
Accumulated Other Comprehensive Income	-1,439	-1,685	-328.55	-975.17	-388.47	-1,312
Retained Earnings	12,302	12,208	11,266	10,922	10,712	10,826
Total Common Shareholders' Equity	13,242	13,310	14,577	13,620	13,989	12,699
Minority Interest	962.89	972.98	1,192	1,206	1,460	1,280
Shareholders' Equity	14,205	14,283	15,769	14,827	15,449	13,979
Total Liabilities & Equity	31,468	31,002	33,567	33,930	35,754	34,367

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	11,029	10,796	10,979	12,050	13,192	13,320
Net Cash (Debt)	-9,790	-9,196	-9,799	-10,647	-11,919	-11,838
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-17.08	-15.79	-16.70	-18.14	-20.32	-20.21
Book Value	13,242	13,310	14,577	13,620	13,989	12,699
Book Value Per Share	23.10	22.85	24.84	23.21	23.85	21.67
Tangible Book Value	-1,861	-1,516	-1,964	-2,392	-3,320	-3,122
Tangible Book Value Per Share	-3.25	-2.60	-3.35	-4.08	-5.66	-5.33

SEC Filings: 10-K · 10-Q